Skip to content

Effects of Transcutaneous Electrical Acupoint Stimulation on the Recovery of Postoperative Gastrointestinal Function in Gynecological Laparoscopic Patients

Effects of Transcutaneous Electrical Acupoint Stimulation on the Recovery of Postoperative Gastrointestinal Function in Gynecological Laparoscopic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001712
Enrollment
Unknown
Registered
2026-07-09
Start date
2026-07-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal dysfunction

Interventions

Transcutaneous electrical acupoint stimulation group:Electrical stimulation was applied bilaterally at acupoints ST36 (Zusanli), ST37 (Shangjuxu), PC6 (Neiguan), and SP6 (Sanyinjiao)
False electro-acupoint stimulation group:In the TEAS group, electrode patches were applied to non-acupoint locations 2 cm adjacent to the designated acupoints for electrical stimulation
Control group:Electrode patches were applied to the specified acupoints

Sponsors

Qingdao Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for elective gynecologic laparoscopic surgery under general anesthesia ASA physical status I–III Aged 18–65 years BMI 18–28 kg/m² Informed consent obtained from the patient or legally authorized representative

Exclusion criteria

Exclusion criteria: Patients with preoperative imaging evidence of gastrointestinal tumor metastasis; local infection at acupoint sites or allergy to electrode patches; cardiac pacemaker implantation; preoperative diagnosis of digestive tract malignancies; previous abdominal or pelvic surgery history; confirmed history of gastrointestinal bleeding or gastroduodenal ulcer; previous gastrointestinal dysfunction under ongoing treatment; preoperative administration of high-dose hormones or steroidal anti-inflammatory drugs; combined hepatic or renal dysfunction; pregnant or lactating women; participation in other clinical trials within the past 3 months

Design outcomes

Primary

MeasureTime frame
Time to first flatus after surgery;

Secondary

MeasureTime frame
ghrelin;motilin;gastrin;cholecystokinin;somatostatin;

Countries

China

Contacts

Public ContactYuan Yang

Qingdao Municipal Hospital

lillian931220@163.com+86 188 4268 0171

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026